Update regarding prescriptions of the Kaleido pump with Dexcom G6
Start Today. Ready for What’s Next At ViCentra the company behind Kaleido, we understand that stability and reliability are essential in diabetes management. That’s
Paulina Takes on Cotopaxi and Chimborazo with Kaleido by Her Side
From quiet trails in the Alps and iconic trails in the Tatras, all the way to the volcanic landscapes of Ecuador, Paulina has a
ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President...
Marketing executive brings 20+ years of global diabetes experience to support European scale-up and next-generation Kaleido launch readiness Utrecht, the Netherlands — January 29,
ViCentra Expands Financing to $98 Million to Accelerate European Commercialization a...
Secures an additional $13 million, bringing the total to $98 million with new investments from ROM Utrecht Region and a consortium of Dutch investors,
Diabetes in the workplace: understanding starts with openness
It is not always easy to do your job when you have diabetes. An unexpected hypo during an important meeting. That look from a
ViCentra Strengthens Leadership Team to Accelerate Growth
Karen Baxter, former VP & GM at Dexcom with deep expertise in diabetes device commercialization across Europe, joins as SVP Sales, Europe Jay Little,